Chair, Stephen V. Liu, MD, Melissa L. Johnson, MD, Benjamin Levy, MD, and Prof. Solange Peters, MD, PhD, discuss NSCLC in this CME/MOC/AAPA activity titled “Amplifying the ADC Advantage: How to Fulfill the Potential of Antibody-Drug Conjugates as the Next Frontier in Precision Lung Cancer Care.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/YEN865. CME/MOC/AAPA credit will be available until July 3, 2024.
- Күн бұрын
Amplifying the ADC Advantage: ADCs as the Next Frontier in Precision Lung Cancer Care
- Рет қаралды 1,655
Пікірлер